|
KR100786927B1
(ko)
|
2000-06-28 |
2007-12-17 |
스미스클라인비이참피이엘시이 |
습식 분쇄방법
|
|
WO2005105814A1
(en)
|
2004-04-28 |
2005-11-10 |
Incyte Corporation |
Tetracyclic inhibitors of janus kinases
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
EP2270014A1
(en)
|
2005-09-22 |
2011-01-05 |
Incyte Corporation |
Azepine inhibitors of janus kinases
|
|
CN103214484B
(zh)
|
2005-12-13 |
2016-07-06 |
因塞特控股公司 |
作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶
|
|
ES2415863T3
(es)
|
2006-12-22 |
2013-07-29 |
Incyte Corporation |
Heterociclos sustituidos como inhibidores de Janus Quinasas
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
HUE029236T2
(en)
|
2007-06-13 |
2017-02-28 |
Incyte Holdings Corp |
(R) -3- (4- (7H-Pyrrolo [2,3-d] pyrimidin-4-yl) -1H-pyrazol-1-yl) -3-cyclopentylpropanenitrile Crystalline salts of Janus kinase inhibitor
|
|
MX2010005300A
(es)
|
2007-11-16 |
2010-06-25 |
Incyte Corp |
4-pirazolil-n-arilpirimidin-2-aminas y 4-pirazolil-n-heteroarilpir imidin-2-aminas como inhibidores de cinasas janus.
|
|
TWI444382B
(zh)
|
2008-03-11 |
2014-07-11 |
Incyte Corp |
作為ｊａｋ抑制劑之氮雜環丁烷及環丁烷衍生物
|
|
CL2009001884A1
(es)
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
PE20211639A1
(es)
|
2009-01-15 |
2021-08-24 |
Incyte Holdings Corp |
Procesos para preparar inhibidores de jak y compuestos intermediarios relacionado
|
|
MY156727A
(en)
|
2009-05-22 |
2016-03-15 |
Incyte Corp |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
EP2432472B1
(en)
|
2009-05-22 |
2019-10-02 |
Incyte Holdings Corporation |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
|
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
MX2012004180A
(es)
|
2009-10-09 |
2012-07-17 |
Incyte Corp |
Derivados de hidroxil, ceto y glucuronido de 3-(4-7h-pirrolo[2,3-d ]pirimidin-a-il)-1h-pirazol-1-il)-3-ciclopentilpropanonitrilo.
|
|
CA2790070C
(en)
|
2010-02-18 |
2018-03-06 |
Incyte Corporation |
Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
|
|
EP3354652B1
(en)
|
2010-03-10 |
2020-05-06 |
Incyte Holdings Corporation |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors
|
|
AR084691A1
(es)
|
2010-05-21 |
2013-06-05 |
Incyte Corp |
Formulacion de uso topico para un inhibidor de jak y metodo para tratar trastorno de la piel
|
|
WO2012068440A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
|
CA2818542A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
WO2012112847A1
(en)
|
2011-02-18 |
2012-08-23 |
Novartis Pharma Ag |
mTOR/JAK INHIBITOR COMBINATION THERAPY
|
|
MY165963A
(en)
|
2011-06-20 |
2018-05-18 |
Incyte Holdings Corp |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
|
CA2844507A1
(en)
|
2011-08-10 |
2013-02-14 |
Novartis Pharma Ag |
Jak pi3k/mtor combination therapy
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
|
JP6359546B2
(ja)
|
2012-11-01 |
2018-07-18 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｊａｋ阻害薬としての三環式縮合チオフェン誘導体
|
|
TWI761825B
(zh)
|
2012-11-15 |
2022-04-21 |
美商英塞特控股公司 |
盧梭利替尼之緩釋性劑型
|
|
MX384910B
(es)
|
2013-03-06 |
2025-03-14 |
Incyte Holdings Corp |
Procesos e intermedios para hacer un inhibidor de jak.
|
|
PE20200527A1
(es)
|
2013-05-17 |
2020-03-09 |
Incyte Corp |
Derivados del bipirazol como inhibidores jak
|
|
SG11201600815WA
(en)
|
2013-08-07 |
2016-03-30 |
Incyte Corp |
Sustained release dosage forms for a jak1 inhibitor
|
|
WO2015026818A1
(en)
|
2013-08-20 |
2015-02-26 |
Incyte Corporation |
Survival benefit in patients with solid tumors with elevated c-reactive protein levels
|
|
SG10201807952PA
(en)
*
|
2014-02-28 |
2018-10-30 |
Incyte Corp |
Jak1 inhibitors for the treatment of myelodysplastic syndromes
|
|
BR112016025427A2
(pt)
|
2014-04-30 |
2017-08-15 |
Incyte Corp |
processos de preparação de um inibidor de jak1 e formas do mesmo
|
|
WO2015184087A2
(en)
|
2014-05-28 |
2015-12-03 |
Institute For Myeloma & Bone Cancer Research |
Anti-cancer effects of jak2 inhibitors in combination with thalidomide derivatives and glucocorticoids
|
|
WO2015184305A1
(en)
*
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
|
NZ751284A
(en)
|
2016-10-03 |
2022-09-30 |
Hangzhou Highlightll Pharmaceutical Co Ltd |
Novel jak1 selective inhibitors and uses thereof
|
|
US10596161B2
(en)
|
2017-12-08 |
2020-03-24 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
JP7393348B2
(ja)
|
2018-01-30 |
2023-12-06 |
インサイト・コーポレイション |
（１－（３－フルオロ－２（トリフルオロメチル）イソニコチニル）ピぺリジン―４－オン）を作製するためのプロセス及び中間体
|
|
UA127519C2
(uk)
|
2018-02-16 |
2023-09-20 |
Інсайт Корпорейшн |
Інгібітори шляху jak1, призначені для лікування порушень, пов'язаних із цитокінами
|
|
JP7565798B2
(ja)
|
2018-03-30 |
2024-10-11 |
インサイト・コーポレイション |
炎症性皮膚疾患のバイオマーカー
|
|
CN113768934A
(zh)
|
2018-03-30 |
2021-12-10 |
因赛特公司 |
使用jak抑制剂治疗化脓性汗腺炎
|
|
MX2020010815A
(es)
|
2018-04-13 |
2020-12-11 |
Incyte Corp |
Biomarcadores para enfermedad de injerto contra hospedero.
|
|
US11596632B2
(en)
|
2018-12-19 |
2023-03-07 |
Incyte Corporation |
JAK1 pathway inhibitors for the treatment of gastrointestinal disease
|
|
PH12021552130A1
(en)
|
2019-03-05 |
2022-08-31 |
Incyte Corp |
Jak1 pathway inhibitors for the treatment of chronic lung allograft dysfunction
|
|
US12360120B2
(en)
|
2019-10-10 |
2025-07-15 |
Incyte Corporation |
Biomarkers for graft-versus-host disease
|
|
CN119930611A
(zh)
|
2019-10-11 |
2025-05-06 |
因赛特公司 |
作为cdk2抑制剂的双环胺
|